These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38757478)

  • 1. Kinetically Inert Platinum (II) Complexes for Improving Anticancer Therapy: Recent Developments and Road Ahead.
    Panda TR; Patra M
    ChemMedChem; 2024 Sep; 19(17):e202400196. PubMed ID: 38757478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Power of Kinetic Inertness in Improving Platinum Anticancer Therapy by Circumventing Resistance and Ameliorating Nephrotoxicity.
    Panda TR; M M; Vaidya SP; Chhatar S; Sinha S; Mehrotra M; Chakraborty S; Gadre S; Duari P; Ray P; Patra M
    Angew Chem Int Ed Engl; 2023 Sep; 62(38):e202303958. PubMed ID: 37314332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.
    Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R
    Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug discovery research in in-vivo antitumor-active azolato-bridged dinuclear Pt(II) complexes].
    Komeda S
    Yakugaku Zasshi; 2012; 132(3):253-9. PubMed ID: 22382827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of chirality on the anticancer activity of Pt(II) and Pt(IV) complexes containing 1
    Papadia P; Barbanente A; Ditaranto N; Hoeschele JD; Natile G; Marzano C; Gandin V; Margiotta N
    Dalton Trans; 2021 Nov; 50(43):15655-15668. PubMed ID: 34673864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Palladium and platinum complexes based on pyridine bases induced anticancer effectiveness via apoptosis protein signaling in cancer cells.
    El-Bendary MM; Akhdhar A; Al-Bogami AS; Domyati D; Kalantan AA; Alzahrani FA; Alamoudi SM; Sheikh RA; Ali EMM
    Biometals; 2024 Aug; 37(4):905-921. PubMed ID: 38361146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fresh platinum complexes with promising antitumor activity.
    Wang X
    Anticancer Agents Med Chem; 2010 Jun; 10(5):396-411. PubMed ID: 20545618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorogenic platinum(IV) complexes as potential predictors for the design of hypoxia-activated platinum(IV) prodrugs.
    Marsh JW; Hacker L; Huang S; Boulet MHC; White JRG; Martin LAW; Yeomans MA; Han HH; Diez-Perez I; Musgrave RA; Hammond EM; Sedgwick AC
    Dalton Trans; 2024 Sep; 53(35):14811-14816. PubMed ID: 39169877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of antitumor azolato-bridged dinuclear platinum(ii) complexes with in vivo antitumor efficacy and unique in vitro cytotoxicity profiles.
    Komeda S; Takayama H; Suzuki T; Odani A; Yamori T; Chikuma M
    Metallomics; 2013 May; 5(5):461-8. PubMed ID: 23608770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, Characterization, and Cytotoxicity Evaluation of Novel Water-Soluble Cationic Platinum(II) Organometallic Complexes with Phenanthroline and Imidazolic Ligands.
    Ali A; Stefàno E; De Castro F; Ciccarella G; Rovito G; Marsigliante S; Muscella A; Benedetti M; Fanizzi FP
    Chemistry; 2024 Jul; 30(38):e202401064. PubMed ID: 38703115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Nanoscale Trans-Platinum(II)-Based Supramolecular Coordination Self-Assembly with a Distinct Anticancer Mechanism.
    He X; Yu J; Yin R; Zhang P; Xiao C; Chen X
    Adv Mater; 2024 May; 36(19):e2312488. PubMed ID: 38301714
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Morpholine or methylpiperazine and salicylaldimine based heteroleptic square planner platinum (II) complexes: In vitro anticancer study and growth retardation effect on E. coli.
    Rahman FU; Ali A; Khan IU; Duong HQ; Yu SB; Lin YJ; Wang H; Li ZT; Zhang DW
    Eur J Med Chem; 2017 May; 131():263-274. PubMed ID: 28334655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biological Evaluation of Dinuclear Platinum(II) Complexes with Aromatic
    Luković D; Franich AA; Živković MD; Rajković S; Stojanović B; Gajović N; Jurišević M; Pavlović S; Simović Marković B; Jovanović M; Stojanović BS; Pavlović R; Jovanović I
    Int J Mol Sci; 2024 Aug; 25(15):. PubMed ID: 39126093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and evaluation of series of diazine-bridged dinuclear platinum(II) complexes through in vitro toxicity and molecular modeling: correlation between structure and activity of Pt(II) complexes.
    Senerovic L; Zivkovic MD; Veselinovic A; Pavic A; Djuran MI; Rajkovic S; Nikodinovic-Runic J
    J Med Chem; 2015 Feb; 58(3):1442-51. PubMed ID: 25551180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs.
    Johnstone TC; Suntharalingam K; Lippard SJ
    Chem Rev; 2016 Mar; 116(5):3436-86. PubMed ID: 26865551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An in vivo active 1,2,5-oxadiazole Pt(II) complex: A promising anticancer agent endowed with STAT3 inhibitory properties.
    Porta F; Facchetti G; Ferri N; Gelain A; Meneghetti F; Villa S; Barlocco D; Masciocchi D; Asai A; Miyoshi N; Marchianò S; Kwon BM; Jin Y; Gandin V; Marzano C; Rimoldi I
    Eur J Med Chem; 2017 May; 131():196-206. PubMed ID: 28324784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor potential of platinum(II) complexes of selenium donor ligands.
    Ahmad S; Isab AA; Al-Arfaj AR
    Metallomics; 2023 Apr; 15(4):. PubMed ID: 36918206
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of Pt(II) complexes of the type [Pt(1,10-phenanthroline)(SArF
    Backman-Blanco G; Valdés H; Ramírez-Apan MT; Cano-Sanchez P; Hernandez-Ortega S; Orjuela AL; Alí-Torres J; Flores-Gaspar A; Reyes-Martínez R; Morales-Morales D
    J Inorg Biochem; 2020 Oct; 211():111206. PubMed ID: 32801098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis of platinum(II) and palladium(II) complexes with 9,9-dihexyl-4,5-diazafluorene and their in vivo antitumour activity against Hep3B xenografted mice.
    Wang QW; Lam PL; Wong RS; Cheng GY; Lam KH; Bian ZX; Ho CL; Feng YH; Gambari R; Lo YH; Wong WY; Chui CH
    Eur J Med Chem; 2016 Nov; 124():537-543. PubMed ID: 27598239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pt(IV) antitumor prodrugs: dogmas, paradigms, and realities.
    Ravera M; Gabano E; McGlinchey MJ; Osella D
    Dalton Trans; 2022 Feb; 51(6):2121-2134. PubMed ID: 35015025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.